<DOC>
	<DOCNO>NCT02183532</DOCNO>
	<brief_summary>Study investigate pharmacokinetics BI 1356 single multiple oral dos 5 mg Chinese healthy subject</brief_summary>
	<brief_title>Pharmacokinetics Single Multiple Oral Doses BI 1356 Healthy Chinese Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Male female Chinese healthy volunteer meet criterion : Persons without clinically remarkable finding clinically evident complication base concurrent illness , past medical history , physical examination , vital sign ( blood pressure , pulse rate , body temperature ) , 12lead Electrocardiogram ( ECG ) , laboratory test result Age ≥18 Age ≤45 year Body weight ≥50 kg BMI ≥19 BMI ≤24 kg/m2 ( Body Mass Index ) Signed date write informed consent prior admission study accordance Good clinical Practice ( GCP ) local legislation Persons deviate norm , show clinical finding ( Blood pressure ( BP ) , Heart rate ( HR ) , ECG ) consultation Persons clinically significant complication Persons gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immune , hormonal disorder Persons central nervous system disorder ( e.g. , epilepsy ) , mental disorder , neurological disorder Persons history significant orthostatic hypotension , syncopal attack , blackout Persons chronic infection severe acute infection Persons history severe allergy/hypersensitivity ( include allergy drug inactive ingredient ) Persons receive drug long halflife ( 24 hour ) within month treatment study , within period 10 time longer halflife drug , study Persons receive drug may theoretically affect study result base information obtain time preparation protocol , within 10 day treatment study ( e.g inhibitor inducer Pgp CYP 3A4 ) Persons participate another trial investigational drug within 4 month treatment study Smokers ( smoke 10 cigarette , 3 cigar , 3 pipe per day ) Persons abstain smoke throughout study Persons undoubtedly abuse alcohol Persons abuse drug Persons donate blood 100 mL within 4 week treatment Persons perform rigorous exercise ( within week treatment study ) Persons laboratory test result outside reference range result consider clinically significant change Persons obey diet rule study centre Persons ECG value outside reference range clinical importance . Examples include , limited , QRS interval &gt; 120 ms. Premenopausal woman ( last menstruation &lt; 1 year prior date informed consent ) : nursing pregnant childbearing potential practicing acceptable method birth control , plan continue use method throughout study agree periodic pregnancy test participation trial . Acceptable method birth control include transdermal patch , intra uterine devices/systems ( IUDs/IUSs ) , oral , implantable injectable contraceptive , sexual abstinence vasectomise partner . No exception make .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>